Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 34Thoracic 3Gynecologic 3Breast 3Head & Neck 2Genitourinary 2Sarcoma 1Lymphoid 1Endocrine 1Dermatologic 1CNS 1

Conditions

Sarcoma 19Neoplasms 7Osteosarcoma 5Gastrointestinal Stromal Tumors 4Neuroblastoma 3Melanoma 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Lung Neoplasms 2Glioma 2Esophageal Neoplasms 2Desmoid Tumors 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Brain Neoplasms 2Wilms Tumor 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Somatostatinoma 1Skin Neoplasms 1Sarcoma, Myeloid 1Sarcoma, Ewing 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplastic Cells, Circulating 1

Interventions

Gemcitabine 9pembrolizumab 7Irinotecan 5Docetaxel 4Cisplatin 4Carboplatin 4Capecitabine 4Albumin-Bound Paclitaxel 4Paclitaxel 3Oxaliplatin 3Leucovorin 3Cyclophosphamide 3Cetuximab 3130-nm albumin-bound paclitaxel 3pazopanib 2palbociclib 2liposomal doxorubicin 2entrectinib 2alectinib 2Vinorelbine 2Trastuzumab 2Taxes 2Radiosurgery 2Oncolytic Virotherapy 2Observation 2Ipilimumab 2Fluorouracil 2Fluorodeoxyglucose F18 2Filgrastim 2Erlotinib Hydrochloride 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Blood Specimen Collection × Sarcoma × Clear all
NCT06332274 2025-05-13

UMBRELLA

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting
717 enrolled
GastrointestinalSarcomaThoracic

Colonic Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡